• Alterations in sequenceand/or expression of genecoding for HDACs have been reported to be implicated in GBM pathogenesisand progression.2,274 In attempts to capitalize onthese revelations, explorations were conducted to evaluate the efficacyof FDA-approved HDAC inhibitors against GBM.275. The gene discussed is HDAC9; the disease is glioblastoma.